Hims & Hers Q4 revenue $167.2M (+97% YoY); achieves first positive adjusted EBITDA of $3.9M

Hims & Hers Health, Inc.

2022-FY EPS reported -$0.32 revenue$526,916,000

Q4 revenue $167.2M, up 97% YoY; full year revenue $526.9M, up 94% YoY.
Q4 net loss narrowed to $10.9M from $31.2M; adjusted EBITDA positive $3.9M (vs -$7.1M).
Subscribers surpassed 1M (1.04M), up 88% YoY; monthly online revenue per subscriber $55.
FY2023 guidance: revenue $735-755M, adjusted EBITDA $20-30M.
Introduced 2025 targets: at least $1.2B revenue and $100M adjusted EBITDA.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Hims & Hers Health, Inc. reported Full Year 2022 results: net income $(65.7) million.

Period: Full Year 2022
Net income: $(65.7) million
Result: reported results

Exact text from the filing

Full year 2022 revenue of $526.9 million, up 94% year-over-year

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Hims & Hers Health, Inc. reported Full Year 2022 results: net income $(65.7) million.

Period: Full Year 2022
Net income: $(65.7) million
Result: reported results

Exact text from the filing

Net loss was $(65.7) million for the year ended December 31, 2022 compared to $(107.7) million for the year ended December 31, 2021.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Hims & Hers Health, Inc. reported Q4 2022 results: revenue $167.2 million, net income $(10.9) million.

Period: Q4 2022
Revenue: $167.2 million
Net income: $(10.9) million
Result: reported results

Exact text from the filing

Q4 2022 record revenue of $167.2 million, up 97% year-over-year Q4 2022 net loss of $10.9 million and achieves Adjusted EBITDA profitability of $3.9 million

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Hims & Hers Health, Inc. reported Full Year 2023 results: revenue $735 million to $755 million. Guidance initiated.

Period: Full Year 2023
Revenue: $735 million to $755 million
Guidance: initiated
Result: guidance update

Exact text from the filing

Provides Q1 and full year 2023 guidance, with full year 2023 revenue in the range of $735 million to $755 million and Adjusted EBITDA in the range of $20 million to $30 million

View on SEC.gov

36 earnings releases filed in the last 30 days. Browse all earnings releases →

Hims & Hers Health, Inc. filing history →

Source: SEC EDGAR

accession 0001773751-23-000027

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.